Sustainable Growth Advisers LP Has $276.09 Million Stock Position in The Cooper Companies, Inc. $COO

Sustainable Growth Advisers LP lessened its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 18.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,368,567 shares of the medical device company’s stock after selling 763,968 shares during the quarter. Cooper Companies makes up approximately 1.9% of Sustainable Growth Advisers LP’s investment portfolio, making the stock its 21st largest position. Sustainable Growth Advisers LP’s holdings in Cooper Companies were worth $276,088,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. New York Life Investment Management LLC increased its position in Cooper Companies by 0.6% during the fourth quarter. New York Life Investment Management LLC now owns 27,344 shares of the medical device company’s stock worth $2,241,000 after buying an additional 158 shares during the last quarter. Allworth Financial LP increased its position in Cooper Companies by 14.1% during the fourth quarter. Allworth Financial LP now owns 1,355 shares of the medical device company’s stock worth $111,000 after buying an additional 167 shares during the last quarter. Mesirow Financial Investment Management Inc. increased its position in Cooper Companies by 1.3% during the third quarter. Mesirow Financial Investment Management Inc. now owns 14,017 shares of the medical device company’s stock worth $961,000 after buying an additional 175 shares during the last quarter. Blue Trust Inc. increased its position in Cooper Companies by 13.9% during the fourth quarter. Blue Trust Inc. now owns 1,515 shares of the medical device company’s stock worth $124,000 after buying an additional 185 shares during the last quarter. Finally, Norden Group LLC increased its position in Cooper Companies by 3.2% during the fourth quarter. Norden Group LLC now owns 6,634 shares of the medical device company’s stock worth $544,000 after buying an additional 205 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Down 1.7%

Shares of COO stock opened at $60.19 on Tuesday. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The stock has a market cap of $11.74 billion, a P/E ratio of 29.80, a price-to-earnings-growth ratio of 1.58 and a beta of 0.88. The stock has a 50 day simple moving average of $65.75 and a 200 day simple moving average of $74.81. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.03 by $0.07. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The firm’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.92 earnings per share. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. On average, research analysts predict that The Cooper Companies, Inc. will post 4.62 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

COO has been the topic of a number of recent analyst reports. Rothschild & Co Redburn downgraded Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target on the stock. in a research report on Wednesday, March 4th. Barclays boosted their price target on Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Piper Sandler set a $86.00 price target on Cooper Companies and gave the stock an “overweight” rating in a research report on Monday. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Finally, Needham & Company LLC boosted their price objective on Cooper Companies from $99.00 to $101.00 and gave the stock a “buy” rating in a report on Friday, March 6th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $88.07.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.